NDC 71335-0220

Gabapentin

Gabapentin

Gabapentin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Gabapentin.

Product ID71335-0220_1c5d7a8f-9329-456c-937e-ce71be65256e
NDC71335-0220
Product TypeHuman Prescription Drug
Proprietary NameGabapentin
Generic NameGabapentin
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2009-11-24
Marketing CategoryANDA / ANDA
Application NumberANDA078428
Labeler NameBryant Ranch Prepack
Substance NameGABAPENTIN
Active Ingredient Strength300 mg/1
Pharm ClassesAnti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 71335-0220-0

20 CAPSULE in 1 BOTTLE (71335-0220-0)
Marketing Start Date2015-02-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71335-0220-1 [71335022001]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA078428
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-02-10

NDC 71335-0220-0 [71335022000]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA078428
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-02-10

NDC 71335-0220-9 [71335022009]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA078428
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-02-10

NDC 71335-0220-3 [71335022003]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA078428
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-02-10

NDC 71335-0220-5 [71335022005]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA078428
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-02-10

NDC 71335-0220-6 [71335022006]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA078428
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-02-10

NDC 71335-0220-2 [71335022002]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA078428
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-02-10

NDC 71335-0220-7 [71335022007]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA078428
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-02-10

NDC 71335-0220-4 [71335022004]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA078428
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-02-10

NDC 71335-0220-8 [71335022008]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA078428
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-02-10

Drug Details

Active Ingredients

IngredientStrength
GABAPENTIN300 mg/1

OpenFDA Data

SPL SET ID:657349fb-41a9-4814-b4ac-4c5afbdde947
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 310432
  • 310431

    • Pharmacological Class

    • Anti-epileptic Agent [EPC]
    • Decreased Central Nervous System Disorganized Electrical Activity [PE]

    NDC Crossover Matching brand name "Gabapentin" or generic name "Gabapentin"

    NDCBrand NameGeneric Name
    0093-4443GabapentinGabapentin
    0093-4444GabapentinGabapentin
    0143-3991GabapentinGabapentin
    0143-3993GabapentinGabapentin
    0143-3994GabapentinGabapentin
    0143-9992GabapentinGabapentin
    0143-9993GabapentinGabapentin
    0143-9994GabapentinGabapentin
    67877-222GabapentinGabapentin
    67877-223GabapentinGabapentin
    67877-224GabapentinGabapentin
    67877-428GabapentinGabapentin
    67877-429GabapentinGabapentin
    68001-006GabapentinGabapentin
    68001-007GabapentinGabapentin
    68071-1212GABAPENTINGABAPENTIN
    68071-1292GabapentinGabapentin
    68071-1808GABAPENTINGABAPENTIN
    68071-1907GABAPENTINGABAPENTIN
    68071-1995GabapentinGabapentin
    68071-3230GABAPENTINGABAPENTIN
    68071-3046GabapentinGabapentin
    68071-3244GabapentinGabapentin
    68071-4087GabapentinGabapentin
    68071-3086GABAPENTINGABAPENTIN
    68071-3383GABAPENTINGABAPENTIN
    68071-3314GABAPENTINGABAPENTIN
    68071-4049GABAPENTINGABAPENTIN
    68071-4241GABAPENTINGABAPENTIN
    68071-4099GabapentinGabapentin
    68071-4113GabapentinGabapentin
    68071-4292GabapentinGabapentin
    68071-4180GabapentinGabapentin
    68071-4090GabapentinGabapentin
    68071-4329GabapentinGabapentin
    68071-4603GabapentinGabapentin
    68071-4169GabapentinGabapentin
    68071-4346GabapentinGabapentin
    68071-4366GabapentinGabapentin
    68071-4729GabapentinGabapentin
    68071-4402GABAPENTINGABAPENTIN
    68071-4784GABAPENTINGABAPENTIN
    68084-774GabapentinGabapentin
    68084-783GabapentinGabapentin
    68084-797GabapentinGabapentin
    68084-762GabapentinGabapentin
    0440-5562GABAPENTINGABAPENTIN
    0440-5563GABAPENTINGABAPENTIN
    68084-802GabapentinGabapentin
    68151-1028GabapentinGabapentin
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.